| Product ID | 63083-2019_7f3c0e6d-b68d-4d76-84c3-7247a5df2cd8 |
| NDC | 63083-2019 |
| Product Type | Human Otc Drug |
| Proprietary Name | DNA Insulin Drops 2019 |
| Generic Name | Dna Insulin Drops |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 1984-08-15 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Professional Complementary Health Formulas |
| Substance Name | CHROMIUM; INSULIN GLULISINE; LYCOPODIUM CLAVATUM SPORE; PANCRELIPASE AMYLASE; PHOSPHORIC ACID; RADIUM BROMIDE; URANYL NITRATE HEXAHYDRATE; VANADIUM |
| Active Ingredient Strength | 6 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL |
| Pharm Classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Insulin Analog [EPC], Insulin [Chemical/Ingredient], Standardized Chemical Allergen [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |